Archive: 26/04/2013

Report updates impact of hypoglycemia in diabetes

(HealthDay)—An update of the current state of knowledge about the impact of hypoglycemia on patients with diabetes reviews outcomes, strategies to prevent hypoglycemia, and current knowledge gaps, and has been published ...

Apr 26, 2013

0

0

Saturday marks sixth annual Rx drug take-back day

(HealthDay)—United States residents across the nation will have an opportunity to safely and anonymously unload expired, unwanted prescription medications on Saturday, April 27, during the sixth annual National Prescription ...

Apr 26, 2013

0

0

Collagenase clostridium histolyticum OK in Peyronie's

(HealthDay)—For patients with Peyronie's disease, treatment with collagenase clostridium histolyticum (CCH) intralesional injections is efficacious and tolerable, according to research published online Feb. 1 in The Journal ...

Apr 26, 2013

0

0

Don't blame parents for sins of the child

(HealthDay)—When the suspects in the Boston Marathon bombings were identified as two brothers—one of them a teenager—many parents wondered, "Who raised these boys?" Mental health experts say it's normal to want to blame ...

Apr 26, 2013

1

0

US sues Novartis in NY again, cites doc kickbacks

The U.S. government sued Novartis Pharmaceuticals Corp. again on Friday, saying it paid kickbacks for a decade to doctors to steer patients toward its drugs, sometimes disguising fishing trips off the Florida coast and trips ...

Apr 26, 2013

Swiss group announces vaccine for Haitian children

(AP)—An executive for a Swiss international foundation says it will soon help Haiti vaccinate thousands of children against contagious rotavirus.

Apr 26, 2013

New approaches in treating complicated childhood polycystic kidney disease

A collaborative team of physician-scientists at the Medical College of Wisconsin (MCW) and Children's Hospital of Wisconsin Research Institute has developed a new evidence-based, clinical algorithm to help physicians treat ...

Apr 26, 2013

New drug stimulates immune system to kill infected cells in animal model of hepatitis B infection

A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of ...

Apr 26, 2013